Phreesia (NYSE:PHR) Given New $30.00 Price Target at KeyCorp

Phreesia (NYSE:PHR) had its price objective raised by KeyCorp from $28.00 to $30.00 in a research report released on Wednesday,Benzinga reports. The firm currently has an overweight rating on the stock.

A number of other research analysts also recently weighed in on the stock. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 target price on shares of Phreesia in a research report on Tuesday, December 10th. Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and raised their price target for the company from $24.00 to $32.00 in a research note on Wednesday. Robert W. Baird dropped their price objective on Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research note on Wednesday, December 11th. Needham & Company LLC reissued a “buy” rating and issued a $29.00 target price on shares of Phreesia in a research note on Tuesday, December 10th. Finally, Truist Financial increased their price target on shares of Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Eleven equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has an average rating of “Buy” and an average price target of $30.64.

Phreesia Stock Performance

Shares of Phreesia stock opened at $28.42 on Wednesday. The firm has a fifty day moving average of $22.50 and a two-hundred day moving average of $22.53. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.77 and a current ratio of 1.74. The stock has a market capitalization of $1.65 billion, a price-to-earnings ratio of -19.33 and a beta of 0.94. Phreesia has a 52 week low of $17.07 and a 52 week high of $29.16.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.04. The business had revenue of $106.80 million during the quarter, compared to analyst estimates of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. Phreesia’s quarterly revenue was up 16.6% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.58) EPS. As a group, equities research analysts predict that Phreesia will post -1.16 EPS for the current year.

Insider Buying and Selling

In related news, SVP David Linetsky sold 2,011 shares of the business’s stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $21.03, for a total value of $42,291.33. Following the transaction, the senior vice president now owns 201,307 shares in the company, valued at $4,233,486.21. The trade was a 0.99 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, General Counsel Allison C. Hoffman sold 1,212 shares of the firm’s stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $21.03, for a total value of $25,488.36. Following the sale, the general counsel now directly owns 119,791 shares of the company’s stock, valued at $2,519,204.73. This represents a 1.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 101,703 shares of company stock worth $2,343,541 in the last 90 days. Insiders own 5.80% of the company’s stock.

Institutional Trading of Phreesia

Several large investors have recently modified their holdings of the stock. International Assets Investment Management LLC lifted its position in shares of Phreesia by 2,179.7% during the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after acquiring an additional 1,395 shares during the period. Lombard Odier Asset Management USA Corp bought a new stake in Phreesia in the second quarter valued at $202,000. Point72 DIFC Ltd acquired a new position in shares of Phreesia during the second quarter valued at about $209,000. XTX Topco Ltd bought a new position in shares of Phreesia during the 3rd quarter worth about $247,000. Finally, Hsbc Holdings PLC bought a new stake in Phreesia in the 2nd quarter valued at about $301,000. Institutional investors and hedge funds own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.